Skip to main content
. 2023 May 18;15(5):1524. doi: 10.3390/pharmaceutics15051524

Table 3.

Recovery and IS-normalized matrix factor (ISN-MF) values of the method in human plasma.

Analyte Nominal Concentration (ng/mL) %Rec (n = 5) CV% ISN-MF (n = 7) CV%
rucaparib 255 101 8 1.02 4
1700 98 3 - -
4250 99 2 0.98 2
niraparib 153 98 2 1.06 2
1020 99 1 - -
2460 98 3 0.97 2
olaparib 357 101 2 0.94 1
2380 103 3 - -
5950 103 3 0.96 2

%Rec, percentage of recovery; CV%, coefficient of variation, ISN-MF, IS-normalized matrix factor; n, number of replicates.